Clinical trial
Hepcidin in Anemic Chronic Heart Failure (CHF) Patients
NCT00437866 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00437866 |
|---|---|
| Title | Hepcidin in Anemic Chronic Heart Failure (CHF) Patients |
| Official title | Hepcidin in the Pathogenesis of Anemia in Patients With Chronic Heart Failure |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Anemia, Chronic Heart Failure |
| Enrollment | 100 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Jul 1, 2010 |
| First posted | Feb 21, 2007 |
| Last update posted | Dec 6, 2012 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: